Concurrently, MK1775 activated the interferon regulatory factor (IRF) pathway, promoting the secretion of CXCL10 and CXCL11, which facilitated CD8+ T-cell infiltration into the tumor microenvironment. Here, CD8A is linked to neoplasm.